Japan has recorded its first death attributed to Mpox, a viral infection formerly known as monkeypox. The victim, a man in his 30s residing in Saitama Prefecture, succumbed to the illness, marking a significant development for the country. The Japanese health ministry, citing information from Reuters, disclosed that the deceased individual had a pre-existing condition of immunodeficiency.
WHO had earlier in May declared that Mpox no longer posed a global health emergency, citing a decline in new cases worldwide. The renaming of the virus from monkeypox was initiated to address concerns related to racism and stigmatization. Mpox, known for causing flu-like symptoms and pus-filled lesions, is primarily transmitted through close contact. While most cases manifest as mild, the infection can potentially be fatal.
Symptoms include high fever, headaches, rashes, muscle aches, back pain, low energy, and swollen lymph nodes, with severe manifestations lasting two to four weeks. The WHO emphasizes that Mpox can be transmitted through physical contact with infectious individuals, contaminated materials, or infected animals.
Japan had initially confirmed its first case of Mpox in July of the preceding year, and this recent fatality highlights the need for continued vigilance and understanding of the virus's implications, particularly among individuals with compromised immune systems.